SafeWork SA

You are here

Go to top of page

Carcinogens authorisation


Any person using, handling or storing prohibited or restricted carcinogens must be authorised to do so.

Applying for authorisation

Application form: Carcinogens - Application to use, handle or store.pdf

Guide for applicants: Carcinogens - Guide for applicants.pdf

Fee: Nil

Note: Please attach all relevant documentation including a statement from a competent person verifying the adequacy of the risk management procedures. A competent person is a person who has acquired through training, qualification or experience the knowledge and skills to carry out the task.

Send your completed form to:

Email: licensing.safework [at] sa.gov.au

Post:

Licensing Unit
SafeWork SA
GPO Box 465
Adelaide SA 5001

Public hospitals

Individual public hospitals (SA Health) do not need to complete this form for cyclophosphamide use as this information is submitted to us by each of the Local Health Networks (LHN). Contact the SA Health LHN WHS Manager for details if you require more information.

List of carcinogens

The following prohibited and restricted carcinogens are listed in Schedule 10 of the Work Health and Safety Regulations 2012 (SA).

Prohibited carcinogens

Item Restricted carcinogenic substance [CAS number]
1 2-Acetylaminofluorene [53-96-3]
2 Aflatoxins
3 4-Aminodiphenyl [92-67-1]
4 Benzidine [92-87-5] and its salts (including benzidine dihydrochloride [531-85-1])
5 bis(Chloromethyl) ether[542-88-1]
6 Chloromethyl methyl ether [107-30-2] (technical grade which contains bis(chloromethyl) ether)
7 4-Dimethylaminoazobenzene [60-11-7] (Dimethyl Yellow)
8 2-Naphthylamine [91-59-8] and its salts
9 4-Nitrodiphenyl [92-93-3]

Restricted carcinogens

Item Restricted hazardous chemical [CAS Number] Details
1 Acrylonitrile [107-13-1] All
2 Benzene [71-43-2]

All uses involving benzene as a feedstock containing more than 50% of benzene by volume

Genuine research or analysis

3 Cyclophosphamide  [50-18-0]

When used in preparation for therapeutic use in hospitals and oncological treatment facilities, and in manufacturing operations

Genuine research or analysis

4 3,3'-Dichlorobenzidine [91-94-1] and its salts (including 3,3'-Dichlorobenzidine dihydrochloride  [612-83-9]) All
5 Diethyl sulfate [64-67-5] All
6 Dimethyl sulfate [77-78-1] All
7 Ethylene dibromide  [106-93-4] 

When used as a fumigant

Genuine research or analysis 

8 4,4'-Methylene  bis(2-chloroaniline)  [101-14-4]MOCA All
9 3-Propiolactone [57-57-8] (Betapropiolactone) All
10 o-Toluidine [95-53-4] and o-Toluidine hydrochloride [636-21-5] All
11 Vinyl chloride monomer [75-01-4] All

Changing application details

You must notify us in writing of any change to the details given on the application form before the change has occurred or as soon as reasonably practicable after the person becomes aware of the change.

Granting or refusing authorisation

In making a decision to grant an authorisation we will consider:

  • whether a prohibited carcinogen is used, handled or stored for genuine research or analysis
  • whether a restricted carcinogen is used, handled or stored for a purpose referred to in table 10.2 of Schedule 10 of the Regulations
  • the quantity of carcinogen to be used, handled or stored at the workplace each year
  • the number of workers that may be exposed to the carcinogen
  • the risk management procedure that contains hazard identification, risk control and, if elimination or substitution of the carcinogen is not reasonably practicable, the reason why. The risk management procedure should include:
    • storage details
    • process description
    • control measures to prevent exposure
    • maintenance and testing procedures for control measures
    • atmospheric monitoring
    • biological monitoring
    • health surveillance program
    • spill and emergency procedures
    • worker training and information
    • decontamination and waste disposal
  • a statement from a competent person verifying the adequacy of the risk management procedures.

We may request additional information to assist in the decision process.

Granting of a conditional authorisation

We may impose any condition it considers necessary on an authorisation to achieve the objectives of the Act or Regulations.

Refusing to grant an authorisation

We will only consider authorising the use, handling or storage of a restricted or prohibited carcinogen if the carcinogen:

  • has an approved use referred to in Regulation 384 of the Regulations
  • is to be used, handled or stored for genuine research or analysis
  • is to be used, handled or stored for a purpose described in table 10.2 of the Regulations.

A decision to refuse to grant an authorisation to use, handle or store a prohibited or restricted carcinogen is a reviewable decision.

Record keeping

The person authorised to use, handle or store prohibited or restricted carcinogens must keep the following records for 30 years after the authorisation ends:

  • a copy of the authorisation including any conditions imposed
  • the full name, date of birth and address of any worker likely to be exposed during the period of the authorisation.

Statement of exposure

The person authorised to use, handle or store prohibited or restricted carcinogens must give to a worker, at the end of the worker’s employment by that person, a written statement of the following:

  • the name of the prohibited or restricted carcinogen to which the worker may have been exposed during their engagement
  • the time the worker may have been exposed
  • how and where the worker may obtain records of the possible exposure
  • whether the worker should undertake regular health assessments, and the relevant tests to undertake.

Cancelling an authorisation

We may cancel an authorisation to use, handle or store a prohibited or restricted carcinogen if we are satisfied that:

  • the person given the authorisation has not complied with a condition of the authorisation
  • the risk to health and safety of a worker using, handling or storing a prohibited or restricted carcinogen has changed since the authorisation was given.

The decision to cancel an authorisation to use, handle or store a prohibited or restricted carcinogen is a reviewable decision.

Safe handling

In recognition of the potential health and safety risks from working with hazardous substances, including cytotoxic drugs, SA Health has developed a policy and risk management guide for South Australian health services.